Ji Qiang, Zhao Yun, Shen JinQiang, Ding WenJun, Xia LiMin, Wang ChunSheng
Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Cardiovascular Surgery, Shanghai Municipal Institute for Cardiovascular Diseases, Shanghai, China.
J Card Surg. 2020 Mar;35(3):528-535. doi: 10.1111/jocs.14455. Epub 2020 Feb 4.
Ischemic mitral regurgitation (IMR) recurrence after combined coronary artery bypass grafting (CABG) and mitral valve repair does occur, with a prevalence of 20% to 30% at the 2- to 4-year follow-up. This single-center study aims to identify the predictors of IMR improvement after surgical revascularization plus mitral valve repair for moderate IMR.
A total of 201 eligible patients were entered into an improved group (n = 141) or a control group (n = 60) according to whether moderate or more mitral regurgitation occurred at the 2-year postoperative time point. Clinical outcomes between groups were compared.
The left ventricular endo-diastolic diameter (LVEDD), type of ring (rigid complete ring), and the use of repair techniques (restrictive annuloplasty associated with subvalvular and/or leaflet repair) were three predictors of IMR improvement after surgery (odds ratio [OR] = 0.921, 95% confidence interval [CI], 0.865-0.976, P = .025; OR = 7.753, 95% CI, 3.168-17.742, P < .001; and OR = 0.168, 95% CI, 0.076-0.423, P = .004, respectively). The cutoff value of the LVEDD was 65 mm with a sensitivity of 80.0% and a specificity of 65.2%. Patients in the improved group compared with those in the control group demonstrated better cumulative survival during a median follow-up of 41.0 months (χ = 4.559, logrank P = .033) and a reduced ratio of the New York Heart Association class III-IV at the latest follow-up (5.7% vs 38.4%, P < .001).
An LVEDD of less than 65 mm, the use of a rigid complete ring, and combined restrictive annuloplasty and subvalvular and/or leaflet repair are associated with IMR improvement after CABG plus mitral valve repair for the treatment of moderate IMR; IMR improvement 2 years after surgery is associated with improved midterm outcomes.
冠状动脉旁路移植术(CABG)联合二尖瓣修复术后缺血性二尖瓣反流(IMR)复发确实存在,在2至4年的随访中,其发生率为20%至30%。这项单中心研究旨在确定手术血运重建加二尖瓣修复治疗中度IMR后IMR改善的预测因素。
根据术后2年时是否出现中度或更严重的二尖瓣反流,将总共201例符合条件的患者分为改善组(n = 141)或对照组(n = 60)。比较两组之间的临床结果。
左心室舒张末期内径(LVEDD)、环的类型(刚性完整环)以及修复技术的使用(与瓣下和/或瓣叶修复相关的限制性瓣环成形术)是术后IMR改善的三个预测因素(比值比[OR]=0.921,95%置信区间[CI],0.865 - 0.976,P = 0.025;OR = 7.753,95%CI,3.168 - 17.742,P < 0.001;以及OR = 0.168,95%CI,0.076 - 0.423,P = 0.004)。LVEDD的临界值为65mm,敏感性为80.0%,特异性为65.2%。与对照组相比,改善组患者在中位随访41.0个月期间表现出更好的累积生存率(χ = 4.559,对数秩检验P = 0.033),并且在最近一次随访时纽约心脏协会III - IV级的比例降低(5.7%对38.4%,P < 0.001)。
对于治疗中度IMR,CABG加二尖瓣修复术后,LVEDD小于65mm、使用刚性完整环以及联合限制性瓣环成形术和瓣下及/或瓣叶修复与IMR改善相关;术后2年IMR改善与中期结果改善相关。